News in the Life Sciences Industry

NEW YORK, Dec. 20, 2018 /PRNewswire/ -- S1 Biopharma, Inc. (S1) announced today that the European Patent Office has granted a European Patent for the Company's proprietary dual-mechanistic therapy Lorexys(TM) for hypoactive sexual desire disorder. A corresponding patent was previously... Read more ››

LUND, Sweden, Dec. 20, 2018 /PRNewswire/ --

LINKÖPING, Sweden, Dec. 20, 2018 /PRNewswire/ --

STOCKHOLM, Dec. 20, 2018 /PRNewswire/ --

STOCKHOLM, Dec. 20, 2018 /PRNewswire/ --

GOTHENBURG, Sweden, Dec. 18, 2018 /PRNewswire/ -- Isofol Medical AB (publ), (Nasdaq First North Premier: ISOFOL) today announced that the first patient has been enrolled in the pivotal Phase 3 AGENT clinical study evaluating arfolitixorin for the treatment of metastatic colorectal cancer (mCRC).... Read more ››

DUBLIN, Dec. 17, 2018 /PRNewswire/ -- A little over a year after raising over EUR 28 million in a private placement, Q3 Medical Devices Limited ("Q3 Medical" or the "Company") based in Dublin, Ireland today announced a new initiative to raise EUR 50 million in a Pre-IPO round that will prepare... Read more ››

STOCKHOLM, Dec. 14, 2018 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that BioArctic and its partner AbbVie (NYSE: ABBV) have received U.S. Federal Trade Commission (FTC) clearance to license BioArctic's alpha-synuclein antibody portfolio for Parkinson's disease... Read more ››

STOCKHOLM, Dec. 14, 2018 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR) today announces that the transformation to focus the company's internal resources on its clinical development projects has now been completed. Redundancies, mainly within research and administration, are reducing... Read more ››